CanCOLD, Canada

Registration Status: Pending

Objective: CanCOLD (Canadian Cohort of Obstructive Lung Disease) is a prospective multi-center cohort study conducted across Canada, dedicated to increase our understanding on the Chronic Obstructive Pulmonary Disease (COPD) and related co-morbidities, to improve its management and to reduce its burden. This first population based long-term COPD cohort study in Canada is set to end in 2023.

Registered Biobank Name CanCOLD
Biobank Leader Wan Tan
Country Canada
Email for biobank inquiries wan.tan@hli.ubc.ca
Principal Investigator Wan Tan
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: